BigBear.ai Holdings (NYSE:BBAI | BBAI Price Prediction) trades at $3.49 as of writing, sitting 43% below its 52-week high of $9.39 and well under its 50-day moving average of $4.18. Our price target for BigBear.ai is $6.16, implying upside of 76.39% over the next 12 months. Confidence is medium, reflecting significant data gaps and a high-volatility profile.
| Metric | Value |
|---|---|
| Current Price | $3.49 |
| 24/7 Wall St. Price Target | $6.16 |
| Upside Potential | 76.39% |
| Recommendation | BUY |
| Confidence Level | 50% (Medium) |
Medium confidence reflects real uncertainty: no formal analyst consensus ratings are available, forward EPS is negative, and beta sits at 3.24. The risk/reward setup reflects a favorable risk/reward profile at current levels.
A Painful Start to 2026
BBAI has declined 35.37% year-to-date and 16.9% over the past month, though BBAI recovered with a 2.05% gain over the past week. Fourth quarter earnings showed revenue of $27.30 million, down 38% year-over-year and gross margin compressed to 20.3% from 37.4% in the prior year. The stock fell 7.32% on the day of the report.
Full-year 2025 was similarly challenging. FY2025 revenue totaled $127.67 million with an operating loss of $213.9 million and free cash flow of negative $46.32 million. Gross margin compressed every quarter, finishing at 20.3% in Q4 versus 37.4% a year earlier. Revenue shortfall stemmed primarily from lower volume on U.S. Army programs and the absence of high-margin one-time contracts that bolstered the prior year.
The Bull Case
Three pillars support upside. First, the Ask Sage acquisition closed in December 2025, bringing a GenAI platform with 100,000+ users across 16,000 government teams and approximately $25 million in annual recurring revenue growing at a six-fold rate year-over-year.
Second, CEO Kevin McAleenan cited the One Big Beautiful Bill, carrying over $170 billion in supplemental DHS funding and $150 billion for DoD disruptive defense technology, as a generational spending catalyst in BigBear.ai’s lane.
Third, the company ended 2025 with $462 million in total cash and investments after reducing debt by more than 90%, enabling additional M&A.
Management guided 2026 revenue of $135 million to $165 million, supported by a backlog exceeding $400 million. If Ask Sage scales as projected and defense spending accelerates, our bull case scenario puts BBAI at $8.24 within 12 months, representing a 136.23% total return.
Downside Risks
Execution risk and macro headwinds threaten the thesis. Revenue declined year-over-year every quarter since Q2 2025, with Q4 delivering a 38% YoY drop. The DOGE initiative and potential government contract terminations threaten revenue, which is heavily reliant on government contracts subject to cancellation.
A material weakness in internal controls and ongoing securities fraud investigation add governance risk. Gross margin compressed from 37.4% to 20.3% in a single year, and adjusted EBITDA losses deepened through 2025.
The stock trades at 13x price-to-sales despite declining revenue and no near-term profitability path. Bulls counter that margin compression and operating losses reflect deliberate Ask Sage integration and R&D investment, not structural deterioration. The $462 million cash position eliminates liquidity risk. In a bear scenario, our model points to a downside floor of $4.55.
The Verdict
The 24/7 Wall St. price target of $6.16 represents a buy at current levels with medium confidence. Our projections assume BBAI achieves 2026 revenue guidance, narrows losses through 2027, and reaches adjusted EBITDA breakeven by 2028 as Ask Sage scales.
Federal budget outcomes, defense AI adoption pace, or further M&A could drive significant upside or downside. The balance sheet has been transformed, the acquisition pipeline is credible, and the defense AI spending backdrop is favorable.
The composite sentiment index sits at a neutral 57.23 with insider activity trending toward net buying, encouraging at these prices. Investors with a 12-to-18-month horizon and tolerance for a beta of 3.24 may find the risk/reward profile compelling. DOGE-driven contract cancellations or a Q1 2026 revenue miss below guidance would signal structural rather than transitional headwinds.
Top Gaining Stocks
Top Losing Stocks